Floatz logo

Indium In 111 Anti-Cd45 Monoclonal Antibody Bc8

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue

Fred Hutchinson Cancer CenterradiopharmaceuticalPhase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

36 Active assets in the Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
SWOG Cancer Research Network
Phase 2BBB
DEXAMETHASONE
Izidore Lossos, MD
Phase 2BBB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
City of Hope Medical Center
Phase 3BBB
VINCRISTINE SULFATE
SWOG Cancer Research Network
Phase 2BB
Fludarabine
UNC Lineberger Comprehensive Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

Indium In 111 Anti-Cd45 Monoclonal Antibody Bc8 is also rated in:

myelodysplastic syndrome with excess blastsDormant
CC
Indicative ·
47 / 100
View asset →
myelodysplastic syndromeDormant
CC
Indicative ·
47 / 100
View asset →
acute myeloid leukemiaDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →